"Designing Growth Strategies is in our DNA"

U.S. Biosimilars Market Size, Share and Industry Analysis By Drug Class (Filgrastim & Pegfilgrastim, Monoclonal Antibodies, Others), By Disease Indication (Cancer, Autoimmune Diseases, Others) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Regional Forecast, 2019 - 2026

The U.S. biosimilars market size was valued at USD 436.1 Million in 2018 and is projected to reach USD 17,696.0 Million by 2026, exhibiting a CAGR of 54.7% in the forecas... Read More

Region : United States | Published Date: Jul, 2019 | Report ID: FBI100990 | Status : Published

 

Request Sample PDF

Refresh Button
U.S. Biosimilars Market Size, Share and Global Industry Trend Forecast till 2025
  • PDF
  • 2018
  • 2015-2017
  • 80
  • Choose License Type
  • 2850
    4850
    6850

Healthcare Clients

DUPONT
Abbott
baxter
lpsos
Logo_Merck_KGaA_2015
chong-kun-dang
DAEWOONG
Natus-Medical
SUANFARMA
Bio-Rad
Intuitive_Surgical_logo
novo-nordisk
Ge-Healthcare
Sedana-Cyan-Black-Tag






We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X